Featured articles from the journal CHEST®, December 2022

Published monthly, the journal CHEST^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The December issue of CHEST contains 36 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“Well-suited for the final issue of 2022, the December issue of the journal CHEST includes articles that look back at lessons learned from the COVID-19 pandemic and insights into planning for future surges,” says Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “’COVID-19: Lessons Learned, Lessons Unlearned, Lessons for the Future’ was written by editorial board members for the critical care section of the journal CHEST and ‘A Regional Command Center for Pandemic Surge’ is a prospective observational study conducted in Catalonia from March 15, 2020, to July 1, 2021.”

Also included in the current issue of the journal CHEST:

• Chest Infections

Recommending constant microbiological surveillance, “Multidrug-Resistant and Extended-Spectrum β-Lactamase Gram-Negative Bacteria in Bilateral Lung Transplant Recipients” discourages the use of empirical broad-spectrum antibiotics.

• Critical Care

A large, multicenter retrospective study, “Inhaled Nitric Oxide vs Epoprostenol During Acute Respiratory Failure” finds large variation in the use of inhaled nitric oxide and inhaled epoprostenol during acute respiratory failure across the United States. A visual abstract for the research can be viewed here.

• Diffuse Lung Disease

Looking at patients with lymphangioleiomyomatosis, “Impact of Age, Menopause, and Sirolimus on Spontaneous Pneumothoraces in Lymphangioleiomyomatosis” research finds increasing age and menopausal status are associated with a reduced risk of development of spontaneous pneumothoraces (SP), and the use of mechanistic target of rapamycin inhibitors is associated with reduced recurrence risk of SP. A visual abstract for the research can be viewed here.

• Thoracic Oncology

The largest study to date on the topic, “Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection” shows that, aside from specific scenarios, safety or risk of bleeding alone should no longer be a deterrent to the use of intrapleural fibrinolytic and enzyme therapy in pleural infection. A visual abstract for the research can be viewed here.

---

Notes for editors

To view the entire December issue of CHEST journal (volume 162, issue 6), published by Elsevier, visit journal.chestnet.org and follow @journal_CHEST on Twitter for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, PR and Communications Specialist, American College of Chest Physicians (CHEST), at [email protected].

About the journal CHEST^®

The journal CHEST, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.org.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.

About Elsevier

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies to help impact makers achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @ElsevierConnect.